共 303 条
- [1] Blackler RW(2015)Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota Br J Pharmacol 172 992-1004
- [2] Motta JP(1977)Resistance of germfree rats to indomethacin-induced intestinal lesions Prostaglandins 14 333-341
- [3] Manko A(2013)NSAID enteropathy: could probiotics prevent it? J Gastroenterol 48 689-697
- [4] Workentine M(2017)Microbiota plays a key role in non-steroidal anti-inflammatory drug-induced small intestinal damage Digestion 95 22-28
- [5] Bercik P(2015)Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID Am J Physiol Gastrointest Liver Physiol 308 994-1003
- [6] Surette MG(2014)Environmental and NSAID-enteropathy: dysbiosis as a common factor Curr Gastroenterol Rep 16 377-1054
- [7] Robert A(2014)Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats J Crohns Colitis 8 1043-3539
- [8] Asano T(2018)Pathophysiology of NSAID-associated intestinal lesions in the rat: luminal bacteria and mucosal inflammation as targets for prevention Front Pharmacol 9 1340-206
- [9] Montalto M(2017)VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function J Cell Physiol 232 3530-982.e3
- [10] Gallo A(2019)The epithelial barrier model shows that the properties of VSL#3 depend from where it is manufactured Endocr Metab Immune Disord Drug Targets 19 199-393